Johnson & Johnson (JNJ) is a company that many investors
are likely familiar with. J&J has been in operation for more than 130
years, and has raised its dividend for 58 years in a row. It has one of the
longest and most impressive histories of any dividend growth stock.
J&J is a long-standing member of the Dividend
Aristocrats.
Not only is Johnson & Johnson a Dividend Aristocrat, it
is a Dividend King as well. The Dividend Kings are an even more exclusive group
of stocks, with 50+ years of consecutive dividend increases. There are just 31
companies that have achieved this accomplishment.
J&J has all of the qualities of a great dividend growth
stock. It has a dividend yield above the S&P 500 average, backed by a
strong brand and highly profitable business model, with potential for long-term
growth.
This article will discuss the quintessential Dividend
Aristocrat that is Johnson & Johnson.
J&J is one of the largest companies in the world, but it
started from very humble beginnings. It was founded all the way back in 1886 by
three brothers, Robert, James, and Edward Johnson. In 1888, the three brothers
published a healthcare manuscript titled “Modern Methods of Antiseptic Wound
Treatment”, which would quickly become the leading standard for antiseptic
surgery techniques.
Over the following decades, the company steadily brought new
products to market. Soon, the company was the leading manufacturer across
several healthcare categories, including baby powder, sanitary napkins, dental
floss, and more.
Today, J&J is a global healthcare giant. It has a market
capitalization of $410 billion, and generates annual revenue of more than $81
billion. J&J is a mega-cap stock, a term to describe stocks with market
caps above $200 billion.
Comments
Post a Comment